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Abstract: I n t r o d u c t i o n: the incidence of oral squamous cell carcinoma (OSCC) comprises about 
2% of all malignant neoplasms. Despite improvement in treatment modalities in OSCC the prognosis 
remains poor.
A i m: the aim of this study is to evaluate clinical and histological predictive factors determining the 
risk of loco-regional recurrence (LRR) and survival of the patients surgically treated for SCC of the 
tongue and the floor of the mouth (FOM).
M a t e r i a l s  &  m e t h o d s: The study group consisted of 60 patients with primary SCC of the tongue 
and FOM who underwent surgical treatment without prior therapy. Clinical and histological factors, 
such as: age, sex of the patients, comorbidities, tumour site, stage, grade, lymph nodes and mandible 
involvement, margin status, type of neck dissection and adjuvant radiation therapy, influencing LRR 
and 5-year disease-specific survival (DSS) were analysed. 
R e s u l t s: LRR was observed in 26 (43.3%) patients after 9.6 months on average (SD ± 9.47) and 
DSS reached 53.3% (95%CI: 40.0–66.3). LRR was more frequent in patients with SCC of the base 
of the tongue (p = 0.024), posterior part of FOM (p = 0.010) and who underwent MRND (p = 0.043). 
Adverse impact on DSS had advanced stage of the disease (p = 0.048) and tongue cancer (p = 0.045). 
In multivariate Cox regression analysis SCC of the tongue achieved the status of independent predic-
tor of LRR (p = 0.028) and DSS (p = 0.011). Lymph node involvement was the second independent 
predictor of LRR (p = 0.008) as well as DSS (p = 0.015).
C o n c l u s i o n s: the analysis of prognostic factors in SCC of tongue and FOM revealed that lymph 
node involvement was an independent predictor of LRR and DSS. Moreover, higher risk of LRR and 
death was observed in patients with tongue cancer, especially localised posteriorly.
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INtRODuCtION
In 2008, 263 020 new cases of malignant neoplasms of the lips and oral cavity 
were registered worldwide. This number of patients, including 170 496 males 
and 92 524 females constituted 2% of all malignant neoplasms [1]. Highly inva-
sive, metastasizing squamous cell carcinoma (SCC) accounts for over 90% of all 
malignancies of the oral cavity. In 60% of cases oral squamous cell carcinoma 
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(OSCC) is localised in the tongue and the floor of the mouth (FOM) [2–4]. The 
risk of occult metastases in patients with OSCC is estimated to be 45% [5–7]. The 
presence of cervical metastases is one of the most important prognostic factors 
affecting the outcome of treatment.
the other clinico-pathological predictive factors in OSCC comprise age of pa-
tients, site, stage and grade of the tumour as well as tumour thickness and 
depth, pattern of invasion, extracapsular extension (ECE), infiltration of bones, 
muscles, blood vessels and nerves [3, 7–10].
the aim of this study is to evaluate clinical and histological predictive factors 
determining the risk of loco-regional recurrence (LRR) and survival of the patients 
surgically treated for SCC of the tongue and FOM.
MAtERIALS AND MEthODS
The study group consisted of the patients with primary SCC of the tongue and 
FOM who underwent surgical treatment in the Department of Cranio-Maxillo-
facial, Oncological and Reconstructive Surgery of the Jagiellonian university in 
Kraków from 2000 to 2011. Clinical and histological factors influencing LRR and 
5-year disease-specific survival (DSS) were analysed. Clinical predictive factors 
comprised age and sex of the patients, tumour site and stage, also the presence 
of comorbidities. Histological predictive factors included SCC’s grade, confirmed 
cervical metastases (pN+), infiltration of the mandible. Prognosis was evaluated 
with regard to radicality of tumour excision, type of neck dissection, postopera-
tive radiation therapy (pORt). Exclusion criteria comprised applied neoadjuvant 
chemotherapy, synchronous and metachronous neoplasms, incomplete follow-up, 
inadequate information concerning survival of the patient or death from other 
causes than OSCC.
Analysis of predictive factors potentially influencing endpoints such as LRR 
and death caused by SCC of the tongue and FOM was conducted for variables 
categorised by 2 test and the Fisher’s exact test for small groups. The Mann–
Whitney’s test was used to compare groups in cases of continuous variables. 
The risk of death and LRR in 5-year period was analysed by logistic regression. 
Graphic analysis of survival was presented using the Kaplan–Meier curves with 
log-rank test. In the multivariate analysis of the influence of chosen prognostic 
factors on the probability of death and LRR the Cox proportional hazard model 
was used. STATA 8.0 was applied, predetermined significance level was p <0.05.
RESuLtS
Between 2000 and 2011, 148 patients with SCC of the tongue and FOM were 
treated in our department. Of these, 60 patients met inclusion criteria. There 
were 46 males and 14 females in the group, the age ranged from 23 to 81 years 
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and was 56.5 years on average. Tongue SCC was diagnosed in 24 (40%) patients 
and SCC of FOM in 36 (60%) cases (Fig. 1, 2). Epidemiologic characteristics of 
the study group statistically did not differ from the remaining patients (table 1). 
The majority of patients, 49 (81.7%) presented in advanced (III or IV) stage of 
disease. The largest group comprised of 32 (53.3%) patients with moderately 
differentiated, partially keratinising SCC.
Surgical treatment included neck dissection, resection of the tumour and im-
mediate reconstruction of the postoperative defects of the oral cavity (Fig. 3). 
Modified radical neck dissection (MRND) on the tumour site was the most com-
mon procedure performed in 34 (56.6%) patients. Bilateral neck dissection was 
carried out in 36 (60%) patients. In SCC of FOM the tumour was resected with 
underlying mandibular bone in 34 (94.4%) cases.
Cervical metastases, in the postoperative specimen, were diagnosed in 29 (48.3%) 
patients, ECE occurred in 5 (8.3%) cases. In cN0 patients occult metastases 
were diagnosed in the histological examination of the postoperative specimen in 
2 (13.3%) patients (table 2).
LRR was observed in 26 (43.3%) patients from 1 month to 44 months, 9.6 mon-
ths on average (SD ± 9.47), following surgery. In the study group DSS reached 
53.3% (95% CI: 40.0–66.3). Death in 24 (85.7%) patients was caused by LRR, in 
3 (10.7%) patients by distant metastases and in one patient by the new primary 
SCC of the soft palate.
Site of the tumour was predictive for LRR and DSS. Prognosis was significantly 
poorer in patients with SCC of the tongue (p = 0.045) and the tendency to higher 
risk of LRR in these patients was observed (p = 0.056) (Fig. 4). Also posterior 
localisation of the tumour in patients with SCC of the tongue enhanced the risk 
of LRR (p = 0.024) and influenced DSS (p = 0.052). LRR was more frequent in 
patients with posterior part of FOM (p = 0.010). Moreover, advanced stage of the 
disease had an adverse impact on prognosis. DSS of the patients with stage III 
and IV reached 46.9% (95% CI: 32.5–61.7) whereas in patients with stage I and 
II was — 81.8% (95% CI: 48.2-97.7) (p = 0.048). Age, sex and comorbidities of 
the patients had no impact on LRR and DSS in the study group (table 3).
the presence of cervical metastases in the postoperative specimen had an 
adverse impact on prognosis. DSS in patients with lymph nodes metastases was 
37.9% (95% CI: 20.7–57.7) whereas in patients without cervical metastases — 
67.7% (95% CI: 48.6- 83.3) (p = 0.021) (Fig. 5). ECE enhanced unfavourable 
prognosis. Death rate in patients with cervical metastases and ECE was 100% 
(p = 0.018). Patients with lymph nodes involvement had higher risk of LRR 
(p = 0.005). tumour grade and infiltration of the mandible had no predictive 
value as well as status of surgical margin and PORT. Higher risk of LRR was 
observed in patients who were treated by MRND (p = 0.043). This was caused 
by the advancement of the disease (table 3).
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Fig. 1. 51-year old patient with SCC G2 of the anterior part of FOM.
Fig. 2. 64-year old patient with SCC G2 of the mobile tongue.
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t a b l e  1
Characteristic of the patients operated due to squamous cell carcinoma of the tongue and the floor 
of the mouth in the period 2000–2011.
total number 
of patients 
n = 148
Study group 
n = 60
the rest of patients 
n = 88 p Value
Age 23–81 yearsMean 56.5 ± 11.74 years
24–87 years
Mean 57.3 ± 10.82 years 0.628
Sex
Men (M)
Women (W)
M:W ratio = 3.3:1
46
14
Men (M)
Women (W)
M:W ratio = 2.7:1
64
24 0.590
Site
tongue
FOMa
24
36
tongue
FOMa
45
43 0.182
Stage
I
II
III
IV
 6
 5
13
36
I   
II
III
IV
Not assessed 
 8
10
24
41
 5
0.594
a FOM — floor of the mouth
t a b l e  2
Characteristic of the study group.
tongue Floor of the mouth
Location Mobile                                 
Base
18                               
6
Anterior part
Medial part
posterior part 
16
13
7
Margin status Adequate                   
Close
positive                
15
1
8
Adequate                   
Close
positive                
24
4
8
Ipsilateral neck 
dissection
MRNDa                                   
SNDb                            
21
3
MRNDa 
SNDb  
14
22
Contralateral neck 
dissection
No  
SNDb
16
8
No
SNDb      
8
28
Lymph node met-
stases 
Yes (ECEc – 2)
No
13
11
Yes (ECEc – 3)
Mo
16
20
Bone resection No 
Rim  
Segment
21
2
1
No 
Rim  
Segment
2
18
16
Bone infiltration No
periostium 
Bone 
23
0
1
No
periostium 
Bone 
21
5
10
Adjuvant therapy pORtd 10 pORtd 16
Loco-regional  
recurrence 14 (58.3%)
3–44 months
Mean 9.1 SD ± 11.1 12 (33.3%)
1–28 months
Mean 10.1 SD ± 7.6
5-year disease- 
specific survival 37.5% 95%CI: 18.8–59.4 63.9% 95%CI: 46.2–79.2
a MRND — modified radical neck dissection, b SND — selective neck dissection, c ECE — extracapsular extension, 
d PORT — postoperative radiotherapy
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Fig. 3. 52-year old patient with SCC G2 of mobile tongue (a), 5 days after hemiglossectomy  
with cervical skin pedicled flap reconstruction (b), 2 months after surgery (c).
79
t a b l e  3
predictors of loco-regional recurrence and 5-year disease specific survival.
Loco-regional recurrence p Value Death p Value
Age
<60 years
≥60 years
16 (41.0%)
10 (47.6%)
0.623 18 (46.1%)
10 (47.6%)
0.914
Sex
men
women
21 (45.6%)
 5 (35.7%)
0.511 21 (45.6%)
 7 (50.0%)
0.775
Site
tongue
FOMa
14 (58.3%)
12 (33.3%)
0.056 15 (62.5%)
13 (36.1%)
0.045
tongue
mobile
base
 8 (44.4%)
 6 (100%)
0.024  9 (50.0%)
 6 (100%)
0.052
FOMa
anterior part
medial part
posterior part
 6 (37.5%)
 2 (15.4%)
 4 (57.1%)
0.010
 4 (25.0%)
 5 (38.4%)
 4 (57.1%)
0.362
Stage
I, II
III, IV
 2 (18.2%)
24 (49.0%)
0.062  2 (18.2%)
26 (53.1%)
0.048
Comorbidities 
no
yes
 9 (40.9%)
17 (44.7%)
0.773 11 (50.0%)
17 (44.7%)
0.694
grade
I
II
III
 3 (27.3%)
21 (45.6%)
 2 (66.7%)
0.383  4 (36.4%)
22 (47.8%)
 2 (66.7%)
0.630
pN(+)
pN(-)
18 (62.1%)
 8 (25.8%)
0.005 18 (62.1%)
10 (32.3%)
0.021
Bone infiltration
no
periostium 
bone
 7 (33.3%)
 2 (40.0%)
 4 (36.4%)
1.000  7 (33.3%)
 2 (40.0%)
 5 (45.4%)
0.890
Margin
adequate                   
close        
positive                          
 9 (56.2%)
 1 (20.0%)
16 (41.0%)
0.348  9 (56.2%)
 1 (20.0%)
18 (46.2%)
0.429
Neck dissection 
MRNDb
SNDc
19 (54.3%)
 7 (28.0%)
0.043 19 (54.3%)
 9 (36.0%)
0.162
Neck dissection
unilateral
bilateral
13 (54.2%)
13 (36.1%)
0.167 14 (58.3%)
14 (38.9%)
0.139
pORtd
no
yes
15 (44.1%)
11 (42.3%)
0.889 17 (50.0%)
11 (42.3%)
0.554
a FOM — floor of the mouth, b MRND — modified radical neck dissection, c SND — selective neck dissection,
d PORT — postoperative radiotherapy
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Fig. 5. Kaplan–Meier survival analysis in relation to lymph nodes involvement  
in the surgical specimen.
Fig. 4. Kaplan–Meier survival analysis in relation to site of squamous cell carcinoma  
in the oral cavity. 
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In univariate analysis localisation of the SCC in the tongue (p = 0.048) and 
lymph node involvement (p = 0.023) had an adverse impact on DSS. It was also 
found that the patients with cervical metastases (p = 0.006) and those who un-
derwent MRND (p = 0.046) had higher risk of LRR (Table 4).
Also in multivariate analysis SCC of the tongue achieved the status of inde-
pendent predictor, had an influence on higher risk of LRR (p = 0.028) and shorter 
DSS (p = 0.011). Lymph node involvement was the second independent predictor 
of LRR (p = 0.008) as well as DSS (p = 0.015) (Table 4).
DISCuSSION
Despite improvement in treatment modalities in OSCC the prognosis remains 
poor. The 5-year overall survival (OS) rate ranges from 32.8% to 56% and the 
5-year DSS rate varies from 41% to 74% [3, 11–13]. Similar results were ob-
served in our study, where 5-year DSS rate was 53.3% (95%CI: 40.0–66.3). The 
prognosis is highly dependent on the histological subtype of the SCC, stage and 
the location of the tumour. Good blood supply as well as the lymphatic drainage 
are the causes of the metastasis in the early stages of cancers of the tongue 
and FOM. therefore, despite the absence of clinical and radiological symptoms 
of tumour spreading, occult metastases are found in 23.1%–45% of patients 
[2, 5, 6]. In our study only 2 (13.3%) patients had occult metastases. Lymph node 
involvement comprises one of the predictors of adverse prognostic significance 
[2, 3, 5]. In the analysed group of patients with confirmed lymph node metas-
tases, the 5-year DSS rate was 37.9% (95%CI: 20.7–57.7) (p = 0.021). Similar 
findings were reported by Woolgar et al., in their group of patients with lymph 
node metastases, operated due to SCC of the oral cavity and the oropharynx, the 
5-year survival rate was 44% [4]. Also the prognosis is worsen by multiple metas-
tases and their location in the IV and V cervical level [3]. In addition, the risk of 
death from cancer is increased by the presence of positive lymph nodes with ECE 
[3, 4, 14]. These findings are in accordance with our results — patients with 
ECE had 100% mortality rate (p = 0.018).
Widely recognised prognosticator in OSCC is the tumour stage. the 5-year 
survival rate in stage I and II is estimated between 65.6% and 96% [15, 16]. 
Similar results were obtained in the present study, in which the 5-year DSS rate 
in the group of patients with stage I and II SCC was 81.8% (95%CI: 48.2–97.7) 
compared to 46.9% (95%CI: 32.5–61.7) survival rate in patients with advanced 
malignancies (p = 0.048).
Controversial prognostic factor in the OSCC is the location of the tumour. 
Most studies show no predictive value of the location of cancer in the oral cav-
ity [3, 15, 17]. However, the present study showed higher percentage of LRR 
(p = 0.056) and higher risk of death (p = 0.045) among patients with tongue can-
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cer. The 5-year DSS rate in patients with tongue cancer was only 37.5% (95%CI: 
18.8–59.4) compared to 63.9% (95%CI: 46.2–79.2) in patients with SCC of FOM. 
Similar results were obtained by Zelefsky et al., who found frequent recurrence 
and poorer prognosis in patients with tongue cancer compared to the SCC of 
FOM [18]. Also Rusthoven et al. showed worse prognosis in the tongue cancer 
than in other sites in the oral cavity [19].
Also patients with more posteriorly located tumours have a lower 5-year surviv-
al. Some studies confirmed worse prognosis as a result of frequent metastasis to 
regional lymph nodes, in SCC of the base of the tongue, as compared to tumours 
located in the mobile tongue [11, 20, 21]. In the present study we also reported 
higher rate of LRR (p = 0.024) and worse survival (p = 0.052) among patients 
with SCC of the base of the tongue. Also posteriorly localised SCC of FOM had 
higher risk of LRR (p = 0.010).
the size of the primary tumour affects both the choice and outcome of treat-
ment. Clinical tumour staging in the tNM classification is based on tumour 
greatest surface dimension for categories T1–T3, and involvement of specific 
structures (such as bone and skin) for T4. Large tumours have a greater risk of 
local recurrence and metastasis to regional lymph nodes, which is associated with 
poor prognosis [3, 7, 8]. However, recent reports indicate that the thickness and 
depth of the tumour are more important than the diameter in predicting nodal 
metastasis and survival, especially in early stage OSCC [14, 22, 23]. In patients 
with SCC of the tongue and the depth of tumour greater than 5 mm lymph 
node involvement is found in over 50% of cases [22]. Tumour thickness is less 
important predictor, especially in the case of exophytic tumours with minimal 
infiltration of stroma [5, 24]. However, risk of nodal metastasis increases in SCC 
of FOM with thickness more than 7.5 mm [23].
the most important feature of SCC is a histological grading. In general, poorly 
differentiated cancers are more aggressive in relation to the moderate and well 
differentiated tumours. However, not always the histological grading, especially in 
the early stages of the disease, correlates with the outcome [2, 5, 22], which was 
also proved in this study. More important histological features, which influence 
outcome, are pattern of invasion and perineural invasion. According to Brand-
wein-Gensler et al., histologic features of cancer, including a widely dispersed 
pattern of tumour invasion, perineural invasion of large nerves (diameter > 1 mm), 
and limited or no lymphoid response of the stroma, are all predictors of high risk 
of local recurrence despite clear surgical margins [10]. Another adverse histologic 
prognosticators are lymphovascular invasion and muscles involvement [5, 9, 25].
Also controversial prognostic factor in OSCC is bone involvement. Some au-
thors concluded that the presence of tumour infiltration of bone adversely affects 
prognosis [8, 14]. The other authors do not support these findings [26, 27]. In 
the present study in the group of patients with and without bone involvement 
LRR rates were similar and amounted 33.3% and 36.4%, respectively.
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prognosis and adjuvant treatment depend on the status of the surgical resec-
tion margins. Distance from invasive carcinoma to surgical margins is measured 
in millimeters. From the surgical point of view, >5 mm is clear, 1–5 mm is close 
and <1 mm is an involved margin [10]. A close or involved surgical margin is 
regarded as a strong predictor of outcome [8, 28]. However, our findings showed 
that the status of the surgical margins did not correlate with LRR and DSS rate, 
as well as in the studies of Kademani et al. and Brandwein-Gensler et al. [10, 29]. 
this might be the result of using frozen section examination in assessing of the 
status of the surgical resection margins, as well as a qualification of patients for 
adjuvant radiotherapy in case of involved margin.
Furthermore, present study showed no predictive value of general and clinical 
factors such as age, sex, comorbidities and the adjuvant radiotherapy. We found 
higher risk of LRR in patients who underwent modified radical neck dissection 
(MRND) (p = 0.043). This relationship may be explained by the fact that the 
MRND was performed in advanced stages of the cancer.
CONCLuSIONS
the analysis of prognostic factors in SCC of tongue and FOM revealed that lymph 
node involvement was an independent predictor of LRR and DSS. Moreover, high-
er risk of LRR and death was observed in patients with tongue cancer, especially 
localised posteriorly. The relatively low 5-year DSS rate in the study group was 
the result of poor oncological awareness of patients. This influenced the progress 
of cancer and postponed the patients decision about the treatment.
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